CytomX Therapeutics, Inc. (CTMX)
Nasdaq: CTMX · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2010
Grade4.4
◀ Past 3.4● Present 5.8▶ Future 3.6
Who runs CytomX Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Mccarthy Sean A.
CEO. First filing Oct 2015, latest Oct 16, 2026, 39 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
33 people on the record since 2015
Officerssales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mccarthy Sean A. | CEO | Oct 2015 | Oct 16, 2026 | 3 · $1.7M |
| Carvajal Alejandra | Chief Legal Officer | Aug 2026 | Aug 5, 2026 | none |
| Ogden Christopher | Chief Financial Officer | Mar 2022 | Jun 17, 2026 | 2 · $100,000 |
| Belvin Marcia | SVP, Chief Scientific Officer | Mar 2023 | Mar 19, 2026 | 1 · $200,000 |
| Chu Yu-Waye | Chief Medical Officer | Jul 2023 | Mar 19, 2026 | 1 · $100,000 |
| Lester Rachael | Chief Business Officer | Oct 2025 | Feb 4, 2026 | none |
Directorssales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Fuchs Charles S. | director | Oct 2017 | Jul 30, 2026 | none |
| Ashworth Alan | director | Oct 2021 | Jun 22, 2026 | none |
| Gilbert Halley E | director | Apr 2020 | Jun 22, 2026 | none |
| Jones Elaine V | director | Oct 2015 | Jun 22, 2026 | none |
| Meyers James R | director | Dec 2018 | Jun 22, 2026 | none |
| Mohindru Mani | director | Dec 2020 | Jun 22, 2026 | none |
| Su Zhen | director | Mar 2024 | Jun 22, 2026 | none |
| Young Matthew P. | director | Oct 2015 | Jun 22, 2026 | none |
Earlier names on the record35, newest filing first
Rowland Lloyd A · officer · last filing Mar 2025Landau Jeffrey B · officer · last filing Aug 2024Campoy Carlos · officer · last filing Mar 2023Peterson Amy C. · officer · last filing Mar 2023Hannah Alison L. · officer · last filing Jul 2022Gluck Frederick W · director · last filing Jun 2022Scarlett John A · director · last filing Jun 2021Biotechnology Value Fund II LP · other · last filing Feb 2021Biotechnology Value Fund L P · other · last filing Feb 2021Biotechnology Value Trading Fund Os LP · other · last filing Feb 2021Bvf Gp Holdings LLC · 10% owner · last filing Feb 2021Bvf I Gp LLC · other · last filing Feb 2021Bvf II Gp LLC · other · last filing Feb 2021Bvf Inc/il · 10% owner · last filing Feb 2021Bvf Partners L P/il · 10% owner · last filing Feb 2021Bvf Partners Os Ltd. · other · last filing Feb 2021Lampert Mark N · 10% owner · last filing Feb 2021Knifsend Robin · officer · last filing Feb 2020Kavanaugh William Michael · officer · last filing Feb 2020Ray Debanjan · officer · last filing Jan 2019Humphrey Rachel · officer · last filing Jan 2019Huh Hoyoung · director · last filing Jun 2018Levin Mark J · 10% owner · last filing Oct 2017Starr Kevin P · 10% owner · last filing Oct 2017Tepper Robert I · 10% owner · last filing Oct 2017Third Rock Ventures Gp, L.P. · 10% owner · last filing Oct 2017Third Rock Ventures LP · 10% owner · last filing Oct 2017Trv Gp, LLC · 10% owner · last filing Oct 2017Exter Neil · director · last filing Jun 2017Mccourt Marion · director · last filing Jun 2017Goeltz II Robert C. · officer · last filing May 2017Canaan Ix L.P. · director · last filing Mar 2017Canaan Partners Ix LLC · director · last filing Mar 2017Ladd Cynthia J · officer · last filing Jan 2017Shannon Timothy M · director · last filing Dec 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.